Aptose Biosciences Inc (NASDAQ:APTO)
| 3.40 Delayed Data As of Jun 18 |  -0.07 / -2.02%Today’s Change | 3.33 Today|||52-Week Range 7.30 | -22.37% Year-to-Date |
Latest APTO News | Press Releases
No recent news for Aptose Biosciences Inc.
Today’s Trading
| Previous close | 3.47 |
| Today’s open | 3.46 |
| Day’s range | 3.38 - 3.53 |
| Volume | 1,172,180 |
| Average volume (3 months) | 3,380,571 |
| Market cap | $303.3M |
Data as of 3:59pm ET, 06/18/2021
Growth & Valuation
| Earnings growth (last year) | -28.84% |
| Earnings growth (this year) | -13.10% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.55 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| APLTApplied Therapeutics... | -1.25 | -5.28% |
| ANIPANI Pharmaceuticals ... | -0.75 | -2.22% |
| FBRXForte Biosciences In... | -1.01 | -2.53% |
| ---- |
Data as of 3:59pm ET, 06/18/2021
Financials
| Next reporting date | August 10, 2021 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$55.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Toronto, Ontario |
Forecasts
